semaglutide settlement Novo Nordisk shares plunged as the Danish company announced its older oral drug failed to slow cognitive decline in late-stage Alzheimer's trials https://reut.rs/4oegPVU | Reuters Novo Nordisk and Viatris Reach

Use of bone graft substitutes in the management of tibial plateau fractures

In January 2025, researchers from Medication Weight Loss Clinic, Ireland, found that GLP-1 agonists showed positive results in managing co-occurring obesity and reducing alcohol intake

This reduced caloric intake can lead to weight loss, as can the inhibition of new fat cell creation resulting from tamed blood sugar

What we do know is that many people regain weight quickly after stopping them, which suggests this may become a lifelong medication for many users, Kevin Thompson, the CEO of 9i Capital Group and the host of the 9innings podcast, told Newsweek

Why Are We Talking About This at Omada

TMAOs effects extend to systemic arterial hypertension and vascular disorders, where elevated levels are associated with unfavorable cardiovascular events